Literature DB >> 11226751

Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system.

E Hösli1, K Jurasin, W Rühl, R Lüthy, L Hösli.   

Abstract

By means of immunohistochemical and electrophysiological methods, we have investigated the presence of androgen receptors on astrocytes in explant and primary cultures from various regions of rat central nervous system. Our studies have shown that a great number of astrocytes and neurones express androgen receptors as recognized by a specific monoclonal antibody. Immunoreactivity was mainly distributed over the soma of the astrocytes, the nuclei being intensely stained. In contrast, glial processes were only faintly stained or not stained. Double-immunostaining studies have provided evidence for a colocalization of androgen and estrogen alpha- and beta-receptors on many astrocytes. Furthermore, there was also a coexistence of glial androgen receptors with cholinergic muscarinic and nicotinic sites. Our immunohistochemical findings are supported by electrophysiological investigations demonstrating that 5alpha-androstan, 17beta-estradiol as well as the cholinergic agonists muscarine and nicotine caused hyperpolarizations on the same astrocytes. Our studies suggest that there is a coexistence of functional receptors for androgen, estrogen as well as for the cholinergic agonists on glial cells. Further investigations are needed to elucidate the physiological role of glial androgen, estrogen and cholinergic receptors and to define their function in neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226751     DOI: 10.1016/s0736-5748(00)00082-4

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  19 in total

Review 1.  Exercise, neurotrophins, and axon regeneration in the PNS.

Authors:  Arthur W English; Jennifer C Wilhelm; Patricia J Ward
Journal:  Physiology (Bethesda)       Date:  2014-11

Review 2.  Estrogens: mechanisms of neuroprotective effects.

Authors:  Suncica Petrovska; Beti Dejanova; Vladimir Jurisic
Journal:  J Physiol Biochem       Date:  2012-02-28       Impact factor: 4.158

Review 3.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Estrogen (17beta-estradiol) enhances glutamine synthetase activity in C6-glioma cells.

Authors:  N Haghighat
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

5.  Lower glial metabolite levels in brains of young children with prenatal nicotine exposure.

Authors:  Linda Chang; Christine C Cloak; Caroline S Jiang; Aaron Hoo; Antonette B Hernandez; Thomas M Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-13       Impact factor: 4.147

6.  The cancer drug tamoxifen: a potential therapeutic treatment for spinal cord injury.

Authors:  Jutatip Guptarak; John E Wiktorowicz; Rovshan G Sadygov; Dragoslava Zivadinovic; Adriana A Paulucci-Holthauzen; Leoncio Vergara; Olivera Nesic
Journal:  J Neurotrauma       Date:  2013-12-11       Impact factor: 5.269

7.  Tyramide Signal Amplification Permits Immunohistochemical Analyses of Androgen Receptors in the Rat Prefrontal Cortex.

Authors:  Katelyn L Low; Chunqi Ma; Kiran K Soma
Journal:  J Histochem Cytochem       Date:  2017-03-01       Impact factor: 2.479

8.  Neuroprotective effects of estrogen and tamoxifen in vitro: a facilitative role for glia?

Authors:  Krishnan Dhandapani; Darrell Brann
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 9.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

10.  Morphological effects of estrogen on cholinergic neurons in vitro involves activation of extracellular signal-regulated kinases.

Authors:  Reymundo Dominguez; Cathy Jalali; Sonsoles de Lacalle
Journal:  J Neurosci       Date:  2004-01-28       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.